Drug Profile
Research programme: cyclin-dependent kinase 2 inhibitors - Roche
Alternative Names: cyclin-dependent kinase 2 inhibitors research programme - Roche; RO 0182986; RO0282986Latest Information Update: 19 Sep 2006
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action Cyclin-dependent kinase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Sep 2006 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 23 Jul 2003 Preclinical trials in Cancer in USA (unspecified route)